Restless Legs Syndrome in Patients With Chronic Kidney Disease

被引:67
作者
Novak, Marta [1 ,2 ]
Winkelman, John W. [3 ]
Unruh, Mark [4 ]
机构
[1] Univ Toronto, Dept Psychiat, Univ Hlth Network, Toronto, ON, Canada
[2] Semmelweis Univ, Inst Behav Sci, H-1085 Budapest, Hungary
[3] Massachusetts Gen Hosp, Dept Psychiat, Sleep Disorders Clin Res Program, Boston, MA 02114 USA
[4] Univ New Mexico, Sch Med, Div Nephrol, Albuquerque, NM 87131 USA
关键词
Chronic kidney disease; dialysis; kidney transplantation; quality of life; restless legs syndrome; sleep; PLACEBO-CONTROLLED TRIAL; QUALITY-OF-LIFE; PERIODIC LIMB MOVEMENTS; DOUBLE-BLIND; HEMODIALYSIS-PATIENTS; GABAPENTIN ENACARBIL; SLEEP DISORDERS; CLINICAL CHARACTERISTICS; CARDIOVASCULAR RISK; DIALYSIS PATIENTS;
D O I
10.1016/j.semnephrol.2015.06.006
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Symptoms of restless legs syndrome (RLS) are common in patients with chronic kidney disease (CKD) on dialysis; symptoms of RLS are estimated to affect up to 25% of patients on dialysis when the international RLS diagnostic criteria are applied. RLS is a neurologic disorder with a circadian rhythmicity characterized by an overwhelming urge to move the legs during rest, which can be relieved temporarily by movement. RLS has been associated with an increase in sleep disturbance, higher cardiovascular morbidity, decreased quality of life, and an increased risk of death in patients with CKD. Although the exact pathophysiology of RLS is unknown, it is thought to involve an imbalance in iron metabolism and dopamine neurotransmission in the brain. The symptoms of moderate to severe RLS can be treated with several pharmacologic agents; however, data specific to patients on dialysis with RLS are lacking. The purpose of this article is to examine the relationship between, and complications of, RLS and CKD both in dialysis and nondialysis patients, and discuss the treatment options for patients on dialysis with RLS. (C) 2015 Published by Elsevier Inc.
引用
收藏
页码:347 / 358
页数:12
相关论文
共 99 条
  • [91] Does the endogenous opiate system play a role in the Restless Legs Syndrome? A pilot post-mortem study
    Walters, Arthur S.
    Ondo, William G.
    Zhu, Wen
    Le, Weidong
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 279 (1-2) : 62 - 65
  • [92] Long-term follow-up on restless legs syndrome patients treated with opioids
    Walters, AS
    Winkelmann, J
    Trenkwalder, C
    Fry, JM
    Kataria, V
    Wagner, M
    Sharma, R
    Hening, W
    Li, L
    [J]. MOVEMENT DISORDERS, 2001, 16 (06) : 1105 - 1109
  • [93] Association of restless legs syndrome and cardiovascular disease in the Sleep Heart Health Study
    Winkelman, John W.
    Shahar, Eyal
    Sharief, Imran
    Gottlieb, Daniel J.
    [J]. NEUROLOGY, 2008, 70 (01) : 35 - 42
  • [94] Winkelman JW, 2007, GERIATRICS, V62, P13
  • [95] Prevalence and correlates of restless legs syndrome symptoms in the Wisconsin Sleep Cohort
    Winkelman, John W.
    Finn, Laurel
    Young, Terry
    [J]. SLEEP MEDICINE, 2006, 7 (07) : 545 - 552
  • [96] Randomized Polysomnography Study of Gabapentin Enacarbil in Subjects with Restless Legs Syndrome
    Winkelman, John W.
    Bogan, Richard K.
    Schmidt, Markus H.
    Hudson, John D.
    DeRossett, Sarah E.
    Hill-Zabala, Christina E.
    [J]. MOVEMENT DISORDERS, 2011, 26 (11) : 2065 - 2072
  • [97] Restless legs syndrome in end-stage renal disease
    Winkelman, JW
    Chertow, GM
    Lazarus, JM
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 28 (03) : 372 - 378
  • [98] Long-term course of restless legs syndrome in dialysis patients after kidney transplantation
    Winkelmann, J
    Stautner, A
    Samtleben, W
    Trenkwalder, C
    [J]. MOVEMENT DISORDERS, 2002, 17 (05) : 1072 - 1076
  • [99] Winkelmann J, 2000, SLEEP, V23, P597